Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
Résumé fourni par la source
The original version of this article has been updated.In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).''Frontiers Media SA PAGE \* Arabic \* MERGEFORMAT 3Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipientsIn the published article, there was a mistake in the Funding statement. The following statement should be removed: TM declares that this study received funding from Sanofi and Bristol Myers Squibb. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
- Date Crossref
- 05/01/2023
- Éditeur
- Frontiers Media SA
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.